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Viswanathan Mohan2, Venkatesan Radha4, Rajendra Pradeepa2 and Karani S. Vimaleswaran1*Abstract
Background: Low vitamin B12 concentrations have been associated with major clinical outcomes, including adiposity,
in Indian populations. The Fat mass and obesity-associated gene (FTO) is an established obesity-susceptibility locus;
however, it remains unknown whether it influences vitamin B12 status. Hence, we investigated the association of two
previously studied FTO polymorphisms with vitamin B12 concentrations and metabolic disease-related outcomes and
examined whether these associations were modified by dietary factors and physical activity.
Methods: A total of 176 individuals with type 2 diabetes, 152 with pre-diabetes, and 220 normal glucose-tolerant
individuals were randomly selected from the Chennai Urban Rural Epidemiology Study. Anthropometric, clinical, and
biochemical investigations, which included body mass index (BMI), waist circumference, vitamin B12, homocysteine,
and folic acid were measured. A validated food frequency questionnaire was used for dietary assessment and self-
reported physical activity measures were collected. An unweighted genetic risk score (GRS) was calculated for two FTO
single-nucleotide polymorphisms (rs8050136 and rs2388405) by summation of the number of risk alleles for obesity.
Interaction analyses were performed by including the interaction terms in the regression model.
Results: The GRS was significantly associated with increased BMI (P = 0.009) and risk of obesity (P = 0.023). Individuals
carrying more than one risk allele for the GRS had 13.13% lower vitamin B12 concentrations, compared to individuals
carrying zero risk alleles (P = 0.018). No associations between the GRS and folic acid and homocysteine concentrations
were observed. Furthermore, no statistically significant GRS-diet or GRS-physical activity interactions with vitamin B12,
folic acid, homocysteine or metabolic-disease outcomes were observed.
Conclusion: The study shows for the first time that a genetic risk score using two FTO SNPs is associated with lower
vitamin B12 concentrations; however, we did not identify any evidence for the influence of lifestyle factors on this
association. Further replication studies in larger cohorts are warranted to investigate the association between the GRS
and vitamin B12 concentrations.
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Obesity and its related comorbidities are leading causes
of mortality and morbidity worldwide [1]. It is estimated
that > 12% of the Indian population is either overweight
or obese [2]. Epidemiological studies have documented
that the increased accessibility of low-cost, high-calorie,
and nutrient-poor foods was among the major driving
forces for the epidemic of obesity [3–5]. This has led to
a substantial increase in the prevalence of obesity-
associated metabolic problems, such as type 2 diabetes
mellitus (T2DM), dyslipidemia, and hypertension in
India [6]. Furthermore, several studies have also dem-
onstrated that obesity is associated with substantial nu-
trient deficiencies, including vitamin B12 [7–9].
Vitamin B12 deficiency is a major public health problem
in India and a recent cross-sectional study conducted in
630 healthy adults in a South Indian population, reported
that 35% of adults were vitamin B12 deficient [10]. An
adequate vitamin B12 concentration is essential for growth,
development, and health. In addition, it is essential for
DNA synthesis, hematological development, and mainten-
ance of the myelin nerve sheaths [11–13]. The primary
causes of vitamin B12 deficiency are age, consumption of
vegetarian diets, and the inability to absorb vitamin B12
from food (via genetic defects or disease) [14, 15]. To date,
several studies have indicated that vitamin B12 status may
be influenced by excess body weight [16, 17]. However, a
recent pooled analysis of 19 studies found no evidence for
an inverse relationship between vitamin B12 and BMI levels
and reported that the majority of observational studies had
a high risk of bias and heterogeneity due to the fact that
most of the studies were not designed to investigate the
association between B12 level and BMI [18]. In light of
these findings, using a genetic approach to explain the gen-
etic mechanisms for obesity and its link with vitamin B12
concentrations could be a better option, in terms of redu-
cing any influence from unmeasured confounding factors.
Genome-wide association studies have identified several
genetic variants related to obesity and type 2 diabetes risk
[19, 20]. To date, the fat mass and obesity-associated (FTO)
gene has been identified as the strongest common genetic
predictor of obesity [21]. Individuals who are homozygous
for FTO risk alleles are on average at 1.67-fold increased
odds of obesity and 3 kg heavier in comparison to individ-
uals without any risk alleles [22]. While several studies have
reported the association between the FTO gene on mea-
sures of body weight and composition, various dietary
parameters and physical activity levels have also been
shown to contribute [23–25]. Recently, a cross-sectional
study in an Indian population showed that physical activity
and dietary intake may modify the association between the
FTO gene variants and obesity-related traits [26]. We used
FTO gene variants as instruments to establish the relation-
ship between obesity and B12 status and tested whetherthis relationship was modified by lifestyle factors. The two
main objectives of this study were first to determine
whether the FTO single-nucleotide polymorphisms (SNPs),
rs8050136, and rs2388405, were associated with obesity
traits, vitamin B12, folic acid, and homocysteine and sec-
ondly whether these associations were modified by diet and
physical activity levels in Asian Indians.
Methodology
Study population
A total of 548 unrelated study subjects were randomly
recruited from the Chennai Urban Rural Epidemiology
Study (CURES) follow-up study, which is an epidemio-
logical study conducted on a representative population
of Chennai, (formerly Madras) in southern India. The
methodology of the study is published elsewhere [27, 28]
and is briefly outlined here (Fig. 1). In phase 1 of CURES,
26,001 (aged ≥ 20 years) individuals were recruited based
on a systematic random sampling technique. In the baseline
survey, of the 26,001 individuals screened, all the individ-
uals with diabetes (phase 2, n = 1382) and 1 in every 10
individuals (phase 3, n = 2207) underwent further detailed
investigations, and these constituted the cohort for the
follow-up study (n = 3589). From these 3589 individuals,
548 individuals, which included: 220 NGT, 152 prediabetic,
and 176 T2DM individuals were randomly selected for this
study. Individuals were excluded from participation if they
were known cases of type 1 diabetes, had diabetes second-
ary to other causes, e.g., chronic pancreatitis, if they were
80 years of age, or were taking vitamin B12 supplements.
Table 1 shows the characteristics of the study participants.
The Madras Diabetes Research Foundation Institu-
tional Ethics Committee granted ethical approval, and
informed consent was obtained from the study partici-
pants. All clinical investigations were conducted accord-
ing to the principles expressed in the Declaration of
Helsinki (ICH GCP).
Phenotype measurements
Anthropometric measurements including weight, height,
and waist circumference were measured using standardized
techniques. The body mass index (BMI) was calculated
using the formula, weight (kg)/height (m2), and obesity was
classified as BMI ≥ 25 according to WHO Asia Pacific
Guidelines for Asians (The Asia Pacific perspective 2000).
Fasting plasma glucose (glucose oxidase–peroxidase
method) was measured using Hitachi-912 Autoanalyser
(Hitachi, Mannheim, Germany). Glycated hemoglobin
(HbA1c) was estimated by high-performance liquid chro-
matography using a Variant™ machine (Bio-Rad, Hercules,
CA, USA). Serum insulin, serum vitamin B12, and folic acid
concentration were estimated using the electrochemilumi-
nescence using a Roche e601Cobas immunoassay analyzer
(Roche Diagnostics, Indianapolis, IN, USA). The intra- and
Table 1 Baseline characteristics of the CURES study participants: comparison of non-obese and obese individuals
Characteristic n Non-obese individuals n Obese individuals P value*
Age (years) 194 51.0 ± 12.8 353 48.4 ± 10.4 0.017
BMI (kg/m2) 194 21.9 ± 2.1 353 29.4 ± 4.1 < 0.001
WC (cm) 194 79.7 ± 8.1 352 93.0 ± 9.9 < 0.001
Hip (cm) 194 89.1 ± 6.1 352 102.4 ± 9.4 < 0.001
WHR 194 0.90 ± 0.08 352 0.91 ± 0.08 0.061
Fasting plasma glucose (mg/dl) 184 119.5 ± 60.3 335 114.7 ± 41.6 0.336
Fasting serum insulin (μIU/ml) 194 8.75 ± 6.36 353 9.57 ± 5.92 0.132
Glycated hemoglobin (%) 194 6.5 ± 1.9 353 6.5 ± 1.6 0.916
Vitamin B12 levels (pg/mL) 194 414.0 ± 219.0 353 420.0 ± 273.0 0.820
Homocysteine 194 14.1 ± 8.2 353 13.4 ± 8.0 0.343
(μmol/L)
Folic acid 194 8.9 ± 5.6 353 8.5 ± 5.9 0.451
(ng/ml)
Total energy intake (kcal) 129 2547.0 ± 784.0 234 2624.0 ± 768.0 0.363
Protein energy % 129 11.3 ± 1.2 234 11.3 ± 1.1 0.947
Carbohydrate energy % 129 63.3 ± 6.7 234 64.9 ± 6.0 0.020
Fat energy % 129 24.2 ± 4.6 234 23.6 ± 4.8 0.293
Total fiber (g) 129 31.6 ± 10.2 234 32.5 ± 11.9 0.513
Physical activity level 123 Low (81.3%) 204 Low (82.4%) 0.929a
Medium (17.1%) Medium (15.7%)
High (1.6%) High (2.0%)
Data shown are represented as means ± SD
P values were calculated by using the Independent t test
*P values for the differences in the means/proportions between non-obese and obese individuals
aP values were calculated by using the chi-squared test
Abbreviations: CURES Chennai Urban Rural Epidemiological Study; BMI body mass index; WC waist circumference; WHR waist to hip ratio
CHENNAI URBAN RURAL EPIDEMIOLOGICAL STUDY (CURES FOLLOW UP STUDY)
CURES Phase 1 (n = 26001)
Phase 2 & 3
Cohort followed (n=3589) 
CURES Phase 2 (n = 1382) CURES Phase 3 (n = 2207)
Follow-up completed
n= 2410 (67.1%)
Normal Glucose Tolerance (NGT)
(n = 220)
Type 2 diabetes (n = 176)
Died n= 534 (14.9%)
Pre-diabetes (n = 152)
Lost to follow up n = 645
(18%)
[Total N=548]
Fig. 1 Flow diagram describing the selection of study participants
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were 0.95% and 4.08%. Serum homocysteine was measured
using enzymatic assay using the Beckman Coulter AU2700
(Fullerton, CA, USA) Biochemistry analyzer.
Dietary assessments and physical activity
Dietary intakes were assessed using a previously vali-
dated and published interviewer-administered semi-
quantitative food frequency questionnaire (FFQ) con-
taining 222 food items to estimate food intake over
the past year. The length of the interview ranged
from 20 and 30 min during which participants were
asked to recall their usual portion size and usual fre-
quency (number of times per day, week, month, or
year/never) of foods listed within the FFQ over the
year. Common household measures such as household
cups, bowls, ladles, spoons (for the cooked foods like
vegetables), wedges, circles of different diameter and
visual atlas of different sizes of fruits (small, medium,
large) were shown to assist the individuals in estimat-
ing portions. A detailed description of the develop-
ment of FFQ and the data on reproducibility and
validity had been published previously [29]. The re-
corded data was analyzed with the EpiNu® software to
estimate energy as well as macronutrient and dietary
fiber intake.
A validated self-report questionnaire was used to
measure physical activity questionnaire [30]. Based on
exercise, leisure time activities, and job-related activities,
respondents were categorized into three groups indicat-
ing activity level (vigorously active, moderately active,
and sedentary). Individuals were graded as vigorously ac-
tive if they did leisure-time exercise and had physically
demanding work, whereas individuals who either exer-
cised or had physically demanding work were catego-
rized as moderately active. All others were categorized
as sedentary.
SNP selection and genotyping
Genetic variants within the FTO gene have shown consist-
ent and strong associations with obesity [21]. Evidence
suggests that the FTO gene confers an increased risk of
obesity by approximately 1.20-fold, and a corresponding
increase in BMI by 0.39 kg/m2 per minor allele [31]. The
BMI-increasing allele in the FTO gene is less prevalent in
Asian (~ 30%) and African populations (~ 12%) than in
European ancestry populations (~ 42%). However, the
effect of the risk alleles on BMI variance is somewhat
similar in the Asian (0.2%), African (0.1%) and European
populations (0.3%) [31–33].
Of particular interest are intronic SNPs, which may
harbor ‘intronic enhancers’ that may exert functional
effects and contain potential transcriptional factor bind-
ing sites. Furthermore, some of these intronic variantshave been shown to increase disease risk or modulate
the genotype-phenotype relationship [34]. The SNP
rs8050136 of the FTO gene has shown consistent and
strong associations with obesity and type 2 diabetes
[21]. Additionally, the SNP rs2388405 was previously se-
lected for analysis in a case-control study conducted in a
Chinese population, due to its possibility of being an ‘in-
tronic enhancer’ [35] and also in a study in a Han Chinese
population [36] and a Caucasian population [37]. Hence,
we selected these two intronic SNPs of the FTO gene with
a known minor allele frequency (MAF) > 15% in the South
Asian population: rs8050136 (intron 1, MAF = 29%;
HapMap South Asian population) and rs2388405 (intron 4,
MAF = 40%; HapMap South Asian population).
The standard Phenol-chloroform method was used to
extract DNA from whole blood [38]. The SNPs
rs8050136 and rs2388405 were genotyped by polymerase
chain reaction on a GeneAmp PCR system 9700 thermal
cycler (Applied Biosystems, Foster City, CA) using the
primers “F: 5′TTT GTT TTG GCT TTC TGC AGT
CT3′, R: CAA AAA CCA CAG GCT CAG A3′ and F:
5′TCT GTG GGA ATC TCC GCT TTC AGT, R: 5′
GAG CCC TTG CGC ATT GCC AG3′ respectively.
The PCR products were digested with MluCI (rs8050136)
and ScaI (rs2388405) restriction enzymes (New England
Biolabs, Inc., Beverly, MA) and the digested products were
resolved by a 3% agarose gel electrophoresis. Based on the
analysis of 200 blind duplicates (20%), there was 100%
concordance in the genotyping. Furthermore, a few vari-
ants were confirmed by direct sequencing with an ABI
310 genetic analyzer (Foster City, CA).
Statistical analysis
The SPSS statistical package (version 22; SPSS Inc.,
Chicago, IL, USA) was used for the statistical ana-
lysis. Allele frequencies were estimated by gene
counting. The chi-square test was used to compare
the proportions of genotypes or alleles. The geno-
typic frequencies in all participants showed no
significant departure from the Hardy Weinberg Equi-
librium (HWE) (P > 0.05) for the FTO rs8050136
(MAF 0.13 and HWE P = 0.749) and rs2388405
(MAF 0.09 and HWE P = 0.259) SNPs.
Generalized obesity was defined according to the World
Health Organization Asia Pacific Guidelines for Asians as
non-obese (BMI < 25 kg/m2 ) and obese (BMI ≥ 25 kg/m2)
[39]. We performed an independent t test to compare the
means of the quantitative variables between individuals
with normal-glucose tolerance (NGT) vs pre-diabetes and
NGT vs T2D). Comparison of the proportion of individuals
engaging in different types of physical activity levels (vigor-
ously active, moderately active, and sedentary) between
NGT individuals vs pre-diabetes and NGT individuals vs
T2D was analyzed by the chi-square test.
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lated for each participant by summation of the number
of risk alleles for obesity. The GRS was generated from
the SNPs rs8050136 and rs2388405 of the FTO gene. A
value of 0, 1, or 2 was assigned to each SNP, which de-
notes the number of risk alleles for obesity on that SNP.
These values were then calculated by adding the number
of risk alleles across each SNP. The risk allele score was
then divided into individuals carrying 0 risk allele vs
more than 1 risk alleles. Association analyses between
the GRS and continuous and categorical variables were
carried out by linear and logistic regression models,
respectively. Linear and logistic regression models were
also used for interaction analyses between GRS and
dietary factors (continuous variables)/physical activity
(categorical variable) on continuous and categorical out-
comes respectively, where the interaction terms were in-
cluded in the models and were adjusted for age, BMI,
sex, T2D, T2D medication, and total energy intake when
appropriate.
Correction for multiple testing was applied using
Bonferroni correction [adjustment P value for associ-
ation analysis was < 0.0083 [1 GRS × 6 biochemical
and metabolic traits (vitamin B12, Homocysteine, folic
acid, obesity, BMI, waist circumference) = 6 tests)] and
for interaction < 0.0017 [1 GRS × 6 biochemical and
metabolic traits × 5 lifestyle factors (dietary carbohy-
drate energy %, dietary protein-energy %, dietary fat
energy %, dietary fiber intake (g), and physical activity
levels) = 30 tests]. Given that there are no studies on
GRS and no previously reported effect sizes for the
South Asians, we were unable to perform a power
calculation for the present study.
Results
Characteristics of the participants
The clinical and biochemical characteristics of the in-
dividuals from the CURES study are illustrated in
Table 1. No significant difference between obese and
non-obese individuals were observed in the levels ofTable 2 Association between the FTO-GRS with vitamin B12, folic ac
Risk alleles n Vitamin B12
(pg/mL)
n Homocysteine
(μmol/L)
n Folic a
(ng/ml
0 380 410 ± 202 390 13.2 ± 7.7 390 8.89 ±
≥ 1 154 356 ± 189 157 14.8 ± 8.9 157 7.89 ±
P value 0.018 0.077 0.147
Values are given as mean ± standard deviation
P values for differences between 0 and 1 risk alleles were obtained using linear reg
medication, and sex
†P values were obtained by using a general linear model adjusted for age, type 2 d
*P values were adjusted for age, sex, and type 2 diabetes status using binary logisti
Abbreviations: BMI body mass index; WC waist circumference; WHR waist to hip ratifasting glucose, insulin, HbA1c, folic acid, homocyst-
eine, vitamin B12 and waist to hip ratio (P>0.05).
However we observed that obese individuals con-
sumed higher quantities of dietary carbohydrate
(energy %) than non-obese individuals (P = 0.020).
The baseline characteristics which compares individ-
uals with NGT, pre-diabetes, and T2D is shown in
Additional file 1: Table S1.Association of B12 level with prediabetes and type 2
diabetes
After adjusting for age, sex, and BMI, there was no asso-
ciation of vitamin B12 level with prediabetes (P = 0.19)
and type 2 diabetes (P = 0.52). Likewise, there was no as-
sociation of vitamin B12 level with prediabetes (P = 0.22)
and type 2 diabetes (P = 0.57) after adjusting for age, sex,
and GRS (as an instrument for BMI).Association between GRS and obesity-related phenotypes
We were able to identify an association between GRS
and BMI (P = 0.009). Individuals who carried more than
one risk allele had higher BMI levels (mean ± SD:
27.55 ± 4.98) compared to individuals with zero risk al-
leles (mean ± SD: 26.43 ± 5.03) (Table 2 and Fig. 2).
Obesity risk-increasing alleles ranged from 0 to 3. The
white bars indicate individuals with 0 risk alleles and the
black bars indicate individuals carrying ≥ 1 alleles. Indi-
viduals who carried 1 or more risk alleles had signifi-
cantly higher BMI compared to individuals carrying 0
risk alleles (P = 0.009)]
There was a significant association between the GRS and
obesity (Passociation = 0.023), where individuals carrying more
than one risk allele had 1.6 times increased risk of obesity
compared to those carrying zero risk alleles (Table 2). How-
ever, after Bonferroni correction, none of these associations
remained statistically significant. Moreover, no statistically
significant associations were observed between GRS and
waist circumference (P = 0.747) (Table 2).id, homocysteine, and obesity traits
cid
)
n BMI
(kg/m2)
n WC
(cm)
n Odds Ratio
(95% CI)
of Obesity
5.92 390 26.4 ± 5.0 390 87.6 ± 11.1 194 1.63 (1.07-2.49)
5.48 157 27.6 ± 5.0 156 90.0 ± 11.6 353
0.009† 0.747 *0.023
ression model adjusted age, BMI, type 2 diabetes status, type 2 diabetes
iabetes status, type 2 diabetes medication, and sex
c regression
o
Fig. 2 Association between the GRS and BMI
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homocysteine, and folic acid levels
We found that the GRS was significantly associated with
vitamin B12 concentrations (P = 0.018) (Table 2 and
Fig. 3), and individuals carrying more than one risk allele
had 13.1% lower vitamin B12 concentrations (mean ±
SD: 355 ± 189 pg/mL), compared to individuals carrying
zero risk alleles (mean ± SD: 410 ± 202 pg/mL). However,
this finding was not significant after correction for mul-
tiple testing.
Obesity risk-increasing alleles ranged from 0 to 3. The
white bars indicate individuals with 0 risk alleles and the
black bars indicate individuals carrying ≥ 1 alleles. Individ-
uals who carried 1 or more risk alleles had significantlyFig. 3 Association between the GRS and serum vitamin B12 levelslower B12 concentrations compared to individuals carry-
ing 0 risk alleles (P = 0.018)] (Fig. 3).
There were no statistically significant associations
between GRS and homocysteine or folic acid concentra-
tions (Table 2).
Interaction between the GRS and lifestyle factors on
vitamin B12, folic acid, homocysteine and obesity traits
None of the lifestyle factors (dietary intake (carbohy-
drate, protein, fat, fiber) or physical activity) significantly
interacted with the GRS on biochemical and anthropo-
metric measurements after correction for multiple test-
ing (Additional file 2: Table S2 and Additional file 3:
Table S3).
Discussion
Both obesity and vitamin B12 deficiency are modifiable
risk factors for several chronic diseases. Moreover, both
risk factors have been shown previously to be associated
with one another. This is the first study to use a genetic
approach to establish a relationship between obesity and
vitamin B12 levels in an Asian Indian population. Our
study confirmed the strength of the association between
the GRS generated from the two FTO SNPs and BMI
and demonstrated the impact of genetically instru-
mented BMI on serum B12 concentrations. These
results suggest that increases in BMI could potentially
contribute to the adverse health effects associated with
vitamin B12 deficiency. Given that low vitamin B12 con-
centrations in Asian Indians are common [10, 40], our
study highlights the importance of considering obesity as
a risk factor for vitamin B12 deficiency with implications
on the possible targeting of relevant obesity prevention
strategies.
Variants of the FTO gene are known to be the stron-
gest genetic predictor of obesity to date [41, 42]. It has
been suggested that risk variants at the FTO locus trig-
ger the overexpression of ghrelin mRNA, leading to
higher levels of the hunger hormone, ghrelin, to be
secreted [43], which in turn makes individuals over con-
sume energy-dense foods [44, 45]. In general, the two
selected intronic SNPs rs2388405 and rs8050136 could
potentially be relevant as intronic enhancers, as they
may enhance the expression of the FTO gene [34]. In
support of this, in a previous study conducted in a South
Indian population (CURES), the FTO SNP, rs8050136,
was associated with an increased risk of obesity [46].
Given the strong role of the FTO locus in obesity [21, 46],
FTO was considered as a suitable candidate to establish
the genetic link between obesity-related traits and vitamin
B12 concentrations.
Reduced vitamin B12 concentrations in the obese popula-
tion are thought to result from a nutrient-poor diet, in-
creased nutrient requirements in relation to increased body
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absorption/metabolism [47, 48]. Additionally, obesity is a
well-known risk factor for T2DM [49] and gastroesopha-
geal reflux disease (GERD) [50]. As a result, obese indi-
viduals are more likely to take metformin and proton
pump inhibitors (PPIs), which have been shown to re-
duce serum B12 levels by inhibiting the absorption of
the vitamin [51, 52]. However, two large Mendelian
randomization studies in populations of European an-
cestry failed to confirm a causal relationship between
low vitamin B12 concentrations and increased BMI
[53, 54]. In our study, we found a significant associ-
ation of the FTO GRS (increased BMI) with low vita-
min B12 concentrations in South Asian adults. Several
studies in India have reported significant phenotypic
associations between vitamin B12 status and obesity-
related traits [9, 16, 55, 56]. A study conducted in
North India reported that there was a negative correl-
ation between waist circumference and reduced levels
of vitamin B12 [55]. A study looking at 2403 school-
going adolescents (11–17 years) from Haryana, India
reported that more than half (51.2%) of obese adoles-
cents were vitamin B12 deficient [9]. Furthermore,
recent findings from the CURES (n = 1500 individuals)
demonstrated that the prevalence of vitamin B12 defi-
ciency significantly increased in those with abdominal
obesity and the mean levels of vitamin B12 signifi-
cantly decreased with increasing degrees of glucose
tolerance [56]. However, in this study, we were unable
to identify a similar trend when considering the GRS,
which could be due to the smaller sample size of our
study (data not shown). However, our data in Asian
Indians confirms the association between vitamin B12
concentrations and obesity and suggests that individ-
uals genetically predisposed to obesity are at a higher
risk of vitamin B12 deficiency. Bi-directional Mendel-
ian randomization studies examining the causal rela-
tionship between B12 level and obesity should be
examined in Europeans and Asian Indians to identify
ethnic specific differences.
Current literature suggests that the genetic profile of an
individual can shape the microbiome of the host, and in-
deed an altered gut flora has been associated with vitamin
B12 deficiency [15, 57]. In a study in rodents, it was found
that the type of dietary lipids (lard or fish oil) influenced
the structure of the microbiome as there was an interaction
between gut microbiota and saturated lipids in promoting
white adipose tissue inflammation [58]. Chakraborty et al.
postulated that a higher concentration of inflammatory
cytokines could impair vitamin B12 absorption or biosyn-
thesis [9]. Another study reported that low vitamin B12
status induced excess triacylglycerol biosynthesis and secre-
tion of pro-inflammatory cytokines [59]. Whether the FTO
genotypes influence the association between obesity andvitamin B12 concentrations by modulating the gut micro-
biota composition and inducing metabolic inflammation
requires further investigation utilizing fecal samples.
The main strength of this study was the use of a vali-
dated food frequency questionnaire [60], which has
shown high reproducibility and validity for total carbo-
hydrates and dietary fiber, and the use of a GRS. More-
over, the sampling was representative of the overall
population of Chennai. Nevertheless, some limitations
need to be acknowledged. Although the majority of In-
dian adults are physically inactive and consume a diet
high in carbohydrates [23, 61], no significant interactions
were found between the GRS and lifestyle factors on
vitamin B12 and metabolic disease outcomes in our
study, which could be attributed to the small sample
size. The GRS only used two variants from the FTO
gene, and we cannot fully exclude that other variants of
the FTO gene may also be important. Furthermore, pre-
vious studies have shown an association of B12 level
with pre-diabetes and T2D [62–64]; hence, it is possible
that the genetic associations identified in this study
could have been mediated through the association of
B12 level with diabetes. But, after adjustment for BMI,
there was no significant association of B12 level with
pre-diabetes and T2D suggesting the effect of GRS on
B12 level in Asian Indians. Another limitation was the
use of a cross-sectional design to investigate genetic
effects at a single point in time and hence no cause-
effect inferences can be drawn, for which a longitudinal
analysis design over a specific time period would be
needed.
In summary, our study, for the first time, suggests that
genetic variations at the FTO locus appear to influence
serum vitamin B12 concentrations in Asian Indians. How-
ever, we were unable to show an impact of the GRS on
lowering B12 concentrations through a dietary influence.
Longitudinal studies and large bi-directional Mendelian
randomization studies could help to establish the causal
relationship between vitamin B12 status and obesity in
Asian Indians.
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